BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vincenzi F, Pasquini S, Borea PA, Varani K. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain. Int J Mol Sci 2020;21:E8710. [PMID: 33218074 DOI: 10.3390/ijms21228710] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hsiao I, Liao H, Cheng C, Yen C, Lin Y. Paper-Based Detection Device for Microenvironment Examination: Measuring Neurotransmitters and Cytokines in the Mice Acupoint. Cells 2022;11:2869. [DOI: 10.3390/cells11182869] [Reference Citation Analysis]
2 Li W, Dai D, Chen A, Gao XF, Xiong L. Characteristics of Zusanli Dorsal Root Ganglion Neurons in Rats and Their Receptor Mechanisms in Response to Adenosine. J Pain 2022;23:1564-80. [PMID: 35472520 DOI: 10.1016/j.jpain.2022.04.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bai H, Zhang Z, Liu L, Wang X, Song X, Gao L. Activation of adenosine A3 receptor attenuates progression of osteoarthritis through inhibiting the NLRP3/caspase-1/GSDMD induced signalling. J Cell Mol Med 2022. [PMID: 35775127 DOI: 10.1111/jcmm.17438] [Reference Citation Analysis]
4 Maniker RB, Damiano J, Ivie RMJ, Pavelic M, Woodworth GE. Perioperative Breast Analgesia: a Systematic Review of the Evidence for Perioperative Analgesic Medications. Curr Pain Headache Rep 2022. [PMID: 35195851 DOI: 10.1007/s11916-022-01031-z] [Reference Citation Analysis]
5 Singh AK, Mahalingam R, Squillace S, Jacobson KA, Tosh DK, Dharmaraj S, Farr SA, Kavelaars A, Salvemini D, Heijnen CJ. Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice. Acta Neuropathol Commun 2022;10:11. [PMID: 35093182 DOI: 10.1186/s40478-022-01315-w] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Zhou M, Wu J, Chang H, Fang Y, Zhang D, Guo Y. Adenosine signaling mediate pain transmission in the central nervous system. Purinergic Signal 2022. [PMID: 35000074 DOI: 10.1007/s11302-021-09826-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jung SM, Peyton L, Essa H, Choi DS. Adenosine receptors: Emerging non-opioids targets for pain medications. Neurobiol Pain 2022;11:100087. [PMID: 35372716 DOI: 10.1016/j.ynpai.2022.100087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wei S, Hao JW, Qiao WL, Li Q, Liu TT, Qiu CY, Hu WP. Suppression of ASIC activity by the activation of A1 adenosine receptors in rat primary sensory neurons. Neuropharmacology 2021;205:108924. [PMID: 34919904 DOI: 10.1016/j.neuropharm.2021.108924] [Reference Citation Analysis]
9 Aminin D, Illes P. Purinergic Signaling in Neuroinflammation. Int J Mol Sci 2021;22:12895. [PMID: 34884700 DOI: 10.3390/ijms222312895] [Reference Citation Analysis]
10 Wang C, Deng H, Wang D, Wang J, Huang H, Qiu J, Li Y, Zou T, Guo L. Changes in metabolomics and lipidomics in brain tissue and their correlations with the gut microbiome after chronic food-derived arsenic exposure in mice. Ecotoxicol Environ Saf 2021;228:112935. [PMID: 34801923 DOI: 10.1016/j.ecoenv.2021.112935] [Reference Citation Analysis]
11 Jacobson KA, Salmaso V, Suresh RR, Tosh DK. Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets. RSC Med Chem 2021;12:1808-25. [PMID: 34825182 DOI: 10.1039/d1md00167a] [Reference Citation Analysis]
12 Abdelkader NF, Ibrahim SM, Moustafa PE, Elbaset MA. Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways. Biomed Pharmacother 2021;145:112395. [PMID: 34775239 DOI: 10.1016/j.biopha.2021.112395] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
13 Wood JN. Pain, purines and Geoff. Auton Neurosci 2021;237:102902. [PMID: 34773738 DOI: 10.1016/j.autneu.2021.102902] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hüll K, Fernández-Dueñas V, Schönberger M, López-Cano M, Trauner D, Ciruela F. Optical Control of Adenosine-Mediated Pain Modulation. Bioconjug Chem 2021;32:1979-83. [PMID: 34448572 DOI: 10.1021/acs.bioconjchem.1c00387] [Reference Citation Analysis]
15 Gazerani P. Nightmares in Migraine: A Focused Review. Behav Sci (Basel) 2021;11:122. [PMID: 34562960 DOI: 10.3390/bs11090122] [Reference Citation Analysis]
16 Coppi E, Cherchi F, Lucarini E, Ghelardini C, Pedata F, Jacobson KA, Di Cesare Mannelli L, Pugliese AM, Salvemini D. Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A3 Receptor Subtype. Int J Mol Sci 2021;22:7952. [PMID: 34360719 DOI: 10.3390/ijms22157952] [Reference Citation Analysis]
17 Garcia-Gil M, Camici M, Allegrini S, Pesi R, Tozzi MG. Metabolic Aspects of Adenosine Functions in the Brain. Front Pharmacol 2021;12:672182. [PMID: 34054547 DOI: 10.3389/fphar.2021.672182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Luongo L, Guida F, Maione S, Jacobson KA, Salvemini D. Adenosine Metabotropic Receptors in Chronic Pain Management. Front Pharmacol 2021;12:651038. [PMID: 33935761 DOI: 10.3389/fphar.2021.651038] [Reference Citation Analysis]
19 Zolkipli-Cunningham Z, Naviaux JC, Nakayama T, Hirsch CM, Monk JM, Li K, Wang L, Le TP, Meinardi S, Blake DR, Naviaux RK. Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder. PLoS One 2021;16:e0248771. [PMID: 33735311 DOI: 10.1371/journal.pone.0248771] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
20 Magni G, Ceruti S. Purines in Pain as a Gliopathy. Front Pharmacol 2021;12:649807. [PMID: 33790798 DOI: 10.3389/fphar.2021.649807] [Reference Citation Analysis]